Displaying 89 (all) recruiting clinical trials.
-
A multicenter open label Phase 2 study to evaluate the efficacy and saftey of Sutetnib maleate capsule in locally advanced or metastatic NSCLC
This study is for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR mutations. The main goal is to see if ...
-
A Randomized Double-Blind Placebo-Controlled Phase 2b Study Evaluating the Safety and Efficacy of Pirfenidone Solution for Inhalation (AP01) in Subjects with Progressive Pulmonary Fibrosis (PPF)
The purpose of this study is to evaluate the safety and efficacy of multiple doses of AP01 compared with placebo (a study treatment containing no ... -
An Open-label Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of EDG-7500 in Adults with Hypertrophic Cardiomyopathy
The purpose of this study is to learn about the safety and tolerability of an investigational study drug called EDG-7500 for the treatment of hypertrophic ... -
A Multicenter Randomized Double-Blind Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients with Postpartum Depression (PPD)
The purpose of collecting your pregnancy information is to see if RE104 has any effects on pregnancy, its outcome, and the birth and health of ... -
A Phase II Clinical Trial of Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
This study is designed to test a treatment called STK-012 for patients with advanced solid tumors. It is an open-label trial, meaning both the researchers ...
-
A Proof-of-Concept Study to Assess the Efficacy Safety and Tolerability of itepekimab (anti-IL-33 mAb) in Participants with Non-Cystic Fibrosis Bronchiectasis
This study aims to evaluate the safety, efficacy, and tolerability of itepekimab in patients with bronchiectasis, in addition to their current treatment regimen, which may ... -
Implementing an effective Diabetes intervEntion Among Low-income immigrants (IDEAL Study)
Dr. Lu Hu and her research team at NYU Langone Health are conducting a study to evaluate the effectiveness of a culturally and linguistically tailored ... -
LINK-IT: Leveraging vIdeos and commuNity health worKers to address socIal determinants of health in Immigrants
The research team led by Dr. Lu Hu at NYU Langone Health is conducting a study to understand whether a culturally and linguistically tailored diabetes ... -
A Phase 2b Randomized Double-blind Placebo-controlled Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of GSBR-1290 in Participants Living with Obesity (Body Mass Index = 30 kg/m2) or Overweight (Body Mass Index = 27 kg/m2) with at Least One Weight-related Comorbidity
This study is evaluating a drug called GSBR-1290, which is being developed by Gasherbrum Bio, Inc. (“the Sponsor”), a biopharmaceutical company with headquarters in the ...